Browse
Register
Log In
Variables
4291 variables.
Search variables
---------
Activity tracker (CHRIS follow-up) (md_x1_0139)
Administrative data (CHRIS baseline) (md_x0_0022)
Administrative data (CHRIS follow-up) (md_x1_0022)
Affinity-based plasma proteomics (CHRIS baseline) (md_x0_0103)
Affinity-based plasma proteomics (Upcoming, CHRIS baseline) (md_up_0011)
Alcohol (CHRIS baseline) (md_x0_0037)
Alcohol (CHRIS follow-up) (md_x1_0037)
Anthropometry (CHRIS baseline) (md_x0_0012)
Anthropometry (CHRIS follow-up) (md_x1_0012)
Anthropometry form (CHRIS follow-up) (md_x1_0135)
Anxiety (CHRIS baseline) (md_x0_0098)
Anxiety (CHRIS follow-up) (md_x1_0098)
Arthritis (CHRIS follow-up) (md_x1_0130)
Autonomic system (CHRIS baseline) (md_x0_0089)
Autonomic system (CHRIS follow-up) (md_x1_0089)
Baseline information (CHRIS COVID-19) (md_cc_0002)
Biochemical traits (CHRIS COVID-19) (md_cc_0003)
Biochemical traits (CHRIS baseline) (md_x0_0002)
Biochemical traits (CHRIS follow-up) (md_x1_0002)
Birth (CHRIS baseline) (md_x0_0038)
Blood (CHRIS COVID-19) (ms_cc_0002)
Blood (CHRIS NAFLD) (ms_na_0002)
Blood (CHRIS PAREGEN1) (ms_p1_0002)
Blood (CHRIS PAREGEN2) (ms_p2_0002)
Blood (CHRIS baseline) (ms_x0_0002)
Blood (CHRIS follow-up) (ms_x1_0002)
Blood collection form (CHRIS baseline) (md_x0_0007)
Blood collection form (CHRIS follow-up) (md_x1_0007)
Blood drawing pain rating (CHRIS follow-up) (md_x1_0134)
Blood measurements (CHRIS baseline) (md_x0_0009)
Blood measurements (CHRIS follow-up) (md_x1_0009)
Blood pressure (CHRIS baseline) (md_x0_0013)
Blood pressure (CHRIS follow-up) (md_x1_0013)
Blood values (CHRIS baseline) (md_x0_0039)
Blood values (CHRIS follow-up) (md_x1_0039)
CHRIS COVID-19 data (md_cc_0001)
CHRIS COVID-19 samples (ms_cc_0001)
CHRIS NAFLD data (md_na_0001)
CHRIS NAFLD samples (ms_na_0001)
CHRIS PAREGEN1 data (md_p1_0001)
CHRIS PAREGEN1 samples (ms_p1_0001)
CHRIS PAREGEN2 data (md_p2_0001)
CHRIS PAREGEN2 samples (ms_p2_0001)
CHRIS baseline data (md_x0_0001)
CHRIS baseline samples (ms_x0_0001)
CHRIS data (md_x_0001)
CHRIS follow-up data (md_x1_0001)
CHRIS follow-up data (Upcoming CHRIS follow-up) (md_up_0010)
CHRIS follow-up samples (ms_x1_0001)
CHRIS samples (ms_x_0001)
CHRIS sub-study data (md_xs_0001)
CHRIS sub-study samples (ms_xs_0001)
COVID-19 infection (CHRIS follow-up) (md_x1_0123)
COVID-19 vaccination (CHRIS follow-up) (md_x1_0117)
Cancer (CHRIS baseline) (md_x0_0040)
Cancer (CHRIS follow-up) (md_x1_0040)
Cardiac arrhythmias (CHRIS baseline) (md_x0_0041)
Cardiac arrhythmias (CHRIS follow-up) (md_x1_0041)
Cardiovascular diseases (CHRIS baseline) (md_x0_0042)
Cardiovascular diseases (CHRIS baseline) (md_x0_0107)
Cardiovascular traits (CHRIS baseline) (md_x0_0114)
Cardiovascular traits (CHRIS follow-up) (md_x1_0114)
Childhood trauma (CHRIS baseline) (md_x0_0081)
Chronic diseases (CHRIS baseline) (md_x0_0043)
Chronic diseases (CHRIS follow-up) (md_x1_0043)
Chronic pain (CHRIS baseline) (md_x0_0044)
Chronic pain (CHRIS follow-up) (md_x1_0124)
Chronotype (CHRIS baseline) (md_x0_0091)
Circulation (CHRIS baseline) (md_x0_0045)
Circulation (CHRIS follow-up) (md_x1_0045)
Clinical traits (CHRIS baseline) (md_x0_0011)
Clinical traits (CHRIS follow-up) (md_x1_0011)
Cognition (CHRIS baseline) (md_x0_0070)
Complement system (CHRIS baseline) (md_x0_0004)
Complement system, additional batch (Upcoming, CHRIS baseline) (md_up_0009)
Continuous blood pressure measurement (CHRIS baseline) (md_x0_0118)
Corticosteroids (Upcoming, CHRIS baseline) (md_up_0008)
Cumulative Illness Rating Scale (CHRIS baseline) (md_x0_0115)
Data-derived traits (CHRIS baseline) (md_x0_0106)
Data-derived traits (CHRIS follow-up) (md_x1_0106)
Day summary (md_x1_0140)
Demographic data (CHRIS baseline) (md_x0_0024)
Demographic data (CHRIS follow-up) (md_x1_0024)
Depression (CHRIS baseline) (md_x0_0090)
Depression (CHRIS follow-up) (md_x1_0090)
Depression and mania (CHRIS baseline) (md_x0_0085)
Derived traits (CHRIS baseline) (md_x0_0104)
Derived traits (CHRIS follow-up) (md_x1_0104)
Diabetes (CHRIS baseline) (md_x0_0046)
Diabetes (CHRIS follow-up) (md_x1_0046)
Drug intake (CHRIS baseline) (md_x0_0018)
Drug intake (CHRIS follow-up) (md_x1_0018)
Drugs complete dataset (CHRIS follow-up) (md_x1_0019)
Drugs summary (CHRIS baseline) (md_x0_0020)
Drugs summary (CHRIS follow-up) (md_x1_0020)
Dynamic consent survey (CHRIS baseline) (md_x0_0109)
ECG 10s (CHRIS baseline) (md_x0_0015)
ECG 10s (CHRIS follow-up) (md_x1_0015)
ECG 20m (CHRIS baseline) (md_x0_0016)
ECG representations based on 32 generative factors (Upcoming, CHRIS baseline) (md_up_0015)
Early repolarization pattern (CHRIS baseline) (md_x0_0116)
Exposure (CHRIS baseline) (md_x0_0047)
Feces (CHRIS NAFLD) (ms_na_0005)
Flavonoid intake (CHRIS baseline) (md_x0_0078)
Flavonoid intake (CHRIS follow-up) (md_x1_0078)
Food frequency questionnaire (CHRIS baseline) (md_x0_0077)
Food frequency questionnaire (CHRIS follow-up) (md_x1_0077)
General health (CHRIS follow-up) (md_x1_0128)
General information (CHRIS COVID-19) (md_cc_0004)
General information (CHRIS baseline) (md_x0_0021)
General information (CHRIS follow-up) (md_x1_0021)
Genomic variants (CHRIS baseline) (md_x0_0026)
Genomics (CHRIS baseline) (md_x0_0025)
Genotype array (CHRIS baseline) (md_x0_0028)
Gynecology (CHRIS baseline) (md_x0_0048)
Gynecology (CHRIS follow-up) (md_x1_0048)
Handedness (CHRIS follow-up) (md_x1_0136)
Heart failure (CHRIS baseline) (md_x0_0049)
Heart failure (CHRIS follow-up) (md_x1_0049)
Heart rate variability (CHRIS baseline) (md_x0_0113)
Heart rate variability, cardiologist curated (CHRIS baseline) (md_x0_0112)
Hypertension (CHRIS follow-up) (md_x1_0116)
Hypomania (CHRIS baseline) (md_x0_0082)
Illness rating (CHRIS follow-up) (md_x1_0129)
Infectious diseases (CHRIS follow-up) (md_x1_0122)
Informed consent (CHRIS follow-up) (md_x1_0110)
Informed consent (CHRIS baseline) (md_x0_0110)
Insomnia (CHRIS follow-up) (md_x1_0121)
Interpretation (CHRIS follow-up) (md_x1_0133)
Interview (CHRIS baseline) (md_x0_0036)
Interview (CHRIS follow-up) (md_x1_0036)
Iron metabolism (CHRIS baseline) (md_x0_0005)
Iron metabolism (Upcoming, CHRIS baseline) (md_up_0003)
Kidney diseases (CHRIS baseline) (md_x0_0050)
Kidney diseases (CHRIS follow-up) (md_x1_0050)
Lab routine measurements (CHRIS baseline) (md_x0_0008)
Lab routine measurements (CHRIS follow-up) (md_x1_0008)
Longitudinal information (CHRIS COVID-19) (md_cc_0005)
MICROS data (md_mi_0001)
MICROS samples (ms_mi_0001)
Major psychiatric diagnoses (CHRIS baseline) (md_x0_0084)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS COVID 19) (md_up_0014)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS baseline, CHRIS NAFLD) (md_up_0007)
Mass-spectrometry plasma proteomics: peptides (CHRIS NAFLD) (md_na_0101)
Mass-spectrometry plasma proteomics: peptides (CHRIS baseline) (md_x0_0101)
Mass-spectrometry plasma proteomics: proteins (CHRIS NAFLD) (md_na_0102)
Mass-spectrometry plasma proteomics: proteins (CHRIS baseline) (md_x0_0102)
Metabolomics (CHRIS NAFLD) (md_na_0063)
Metabolomics (CHRIS baseline) (md_x0_0063)
Metagenomes from saliva and feces (Upcoming, CHRIS NAFLD) (md_up_0016)
Migraine (CHRIS baseline) (md_x0_0051)
Mitochondrial DNA (Upcoming, CHRIS baseline) (md_up_0019)
Mitochondrial DNA copy number (CHRIS baseline) (md_x0_0006)
Movement disorder examination (CHRIS baseline) (md_x0_0111)
Myocardial infarction (CHRIS baseline) (md_x0_0052)
Myocardial infarction (CHRIS follow-up) (md_x1_0052)
NAFLD sub-study data (Upcoming CHRIS NAFLD) (md_up_0006)
NOT IN USE (md_x_0003)
NOT IN USE md_x0_0033 (md_x0_0033)
NOT IN USE md_x0_0034 (md_x0_0034)
NOT IN USE md_x0_0122 (md_x0_0122)
NOT IN USE md_x0_0123 (md_x0_0123)
NOT IN USE md_x0_0124 (md_x0_0124)
NOT IN USE md_x0_0125 (md_x0_0125)
NOT IN USE ms_x0_0005 (ms_x0_0005)
NOT IN USE ms_x0_0006 (ms_x0_0006)
NOT IN USE ms_x0_0007 (ms_x0_0007)
NOT IN USE ms_x0_0008 (ms_x0_0008)
NOT IN USE ms_x0_0009 (ms_x0_0009)
NOT IN USE ms_x0_0010 (ms_x0_0010)
NOT IN USE ms_x0_0011 (ms_x0_0011)
NOT IN USE test (test)
NOT IN USE upcoming_0001 (upcoming_0001)
NOT IN USE upcoming_0002 (upcoming_0002)
NOT IN USE upcoming_0003 (upcoming_0003)
NOT IN USE upcoming_0004 (upcoming_0004)
Neurological phenotypes (CHRIS baseline) (md_x0_0108)
Neurological phenotypes (CHRIS follow-up) (md_x1_0108)
Neurological tests (CHRIS baseline) (md_x0_0068)
Neurological tests (CHRIS follow-up) (md_x1_0068)
Neurology (CHRIS baseline) (md_x0_0053)
Neurology (CHRIS follow-up) (md_x1_0053)
Neuropsychiatry questionnaire (CHRIS baseline) (md_x0_0080)
Neutralizing Antibody (CHRIS COVID-19) (md_cc_0006)
Notes (CHRIS follow-up) (md_x1_0138)
Nutrient intake (CHRIS baseline) (md_x0_0079)
Nutrient intake (CHRIS follow-up) (md_x1_0079)
Nutrition (CHRIS baseline) (md_x0_0054)
Occupation (CHRIS baseline) (md_x0_0055)
Occupation (CHRIS follow-up) (md_x1_0055)
Olfaction (CHRIS follow-up) (md_x1_0118)
Olfactory test (CHRIS baseline) (md_x0_0071)
Olfactory test (CHRIS follow-up) (md_x1_0071)
Optimism and pessimism (CHRIS baseline) (md_x0_0083)
Oral health (CHRIS baseline) (md_x0_0099)
Other diseases (CHRIS baseline) (md_x0_0056)
PAREGEN sub-study data (Upcoming, CHRIS PAREGEN) (md_up_0017)
PAREGEN2 sub-study data (Upcoming, CHRIS PAREGEN2) (md_up_0018)
Pain Sensitivity (CHRIS follow-up) (md_x1_0092)
Pain pressure threshold (CHRIS baseline) (md_x0_0069)
Pain sensitivity (CHRIS baseline) (md_x0_0092)
Pain sensitivity assessement (CHRIS follow-up) (md_x1_0119)
Pain staging (CHRIS follow-up) (md_x1_0125)
Parkinson screening (CHRIS baseline) (md_x0_0057)
Participant satisfaction survey (CHRIS follow-up) (md_x1_0132)
Participation information (CHRIS baseline) (md_x0_0023)
Participation information (CHRIS follow-up) (md_x1_0023)
Pedigree (CHRIS baseline) (md_x0_0074)
Person (CHRIS baseline) (md_x0_0058)
Person (CHRIS follow-up) (md_x1_0058)
Physical activity (CHRIS baseline) (md_x0_0093)
Physical activity (CHRIS follow-up) (md_x1_0093)
Proteomics (CHRIS NAFLD) (md_na_0100)
Proteomics (CHRIS baseline) (md_x0_0100)
Public imputation panels (CHRIS baseline) (md_x0_0027)
REM sleep (CHRIS baseline) (md_x0_0095)
REM sleep (CHRIS follow-up) (md_x1_0095)
Raw recordings ECG 10s (CHRIS baseline) (md_x0_0119)
Raw recordings ECG 20m (CHRIS baseline) (md_x0_0120)
Raw recordings spiralography (CHRIS baseline) (md_x0_0121)
Renin-angiotensin-aldosteron system (Upcoming, CHRIS baseline) (md_up_0005)
Resting ECG (CHRIS baseline) (md_x0_0014)
Resting ECG (CHRIS follow-up) (md_x1_0014)
Restless Legs Syndrome (CHRIS baseline) (md_x0_0096)
SARS-CoV-2 antibody (CHRIS follow-up) (md_x1_0115)
Saliva (CHRIS NAFLD) (ms_na_0004)
Saliva (CHRIS baseline) (ms_x0_0004)
Saliva microbiome (Upcoming, CHRIS baseline) (md_up_0013)
Sample-derived traits (CHRIS baseline) (md_x0_0105)
Sample-derived traits (CHRIS follow-up) (md_x1_0105)
Self-Assessement (CHRIS baseline) (md_x0_0076)
Self-Assessement (CHRIS follow-up) (md_x1_0076)
Self-Assessement at home (CHRIS follow-up) (md_x1_0127)
Self-reported ancestry (CHRIS baseline) (md_x0_0075)
Sleep behavior (CHRIS follow-up) (md_x1_0120)
Sleep quality (CHRIS baseline) (md_x0_0094)
Smoking (CHRIS baseline) (md_x0_0059)
Smoking (CHRIS follow-up) (md_x1_0059)
Socio-economic panel (CHRIS follow-up) (md_x1_0126)
Socio-economic panel, at home (CHRIS follow-up) (md_x1_0131)
Spiralography (CHRIS baseline) (md_x0_0072)
Stress perception (CHRIS baseline) (md_x0_0086)
Stroke (CHRIS baseline) (md_x0_0060)
Stroke (CHRIS follow-up) (md_x1_0060)
Summary (md_x1_0141)
Surgeries (CHRIS follow-up) (md_x1_0137)
TOPMed-imputed genotypes (CHRIS baseline) - NOT IN USE (md_x0_0030)
Targeted serum metabolomics (CHRIS NAFLD) (md_na_0065)
Targeted serum metabolomics (CHRIS baseline) (md_x0_0065)
Targeted serum metabolomics, expanded set (CHRIS baseline) (md_x0_0064)
Targeted serum metabolomics, expanded set (Upcoming, CHRIS baseline) (md_up_0004)
Temperament (CHRIS baseline) (md_x0_0087)
Thyroid diseases (CHRIS baseline) (md_x0_0061)
Thyroid diseases (CHRIS follow-up) (md_x1_0061)
Touchscreen (CHRIS baseline) (md_x0_0088)
Touchscreen (CHRIS follow-up) (md_x1_0088)
Untargeted serum metabolomics (Upcoming, CHRIS baseline) (md_up_0012)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS NAFLD) (md_na_0066)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS baseline) (md_x0_0066)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS NAFLD) (md_na_0067)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS baseline) (md_x0_0067)
Upcoming datasets (md_up_0001)
Urine (CHRIS NAFLD) (ms_na_0003)
Urine (CHRIS baseline) (ms_x0_0003)
Urine (CHRIS follow-up) (ms_x1_0003)
Urine measurements (CHRIS baseline) (md_x0_0010)
Urine measurements (CHRIS follow-up) (md_x1_0010)
Vaccination (CHRIS baseline) (md_x0_0062)
Vaccination status (CHRIS COVID-19) (md_cc_0007)
Whole-exome sequencing (CHRIS baseline) (md_x0_0029)
Whole-exome sequencing imputation (CHRIS baseline) (md_x0_0031)
Whole-exome sequencing raw data (CHRIS baseline) (md_x0_0032)
Without expected release date (md_up_0002)
Module
---------
Label
Character
Integer
Categorical
Float
Date
Time
Datetime
Boolean
Type
Search
Clear
Module
Label
Name
Description
Type
Biochemical traits (CHRIS COVID-19)
cclp91b
Maglumi SARS-CoV-2 IgM
Maglumi SARS-CoV-2 IgM
Float
Blood measurements (CHRIS baseline)
x0lp26a
Magnesium (Mg)
Magnesium (Mg)
Float
Blood measurements (CHRIS baseline)
x0lp26
Magnesium (Mg)
Magnesium (Mg)
Float
Heart rate variability, cardiologist curated (CHRIS baseline)
x0ec42
Maximum Heart Rate
maximum HR
Float
Blood measurements (CHRIS baseline)
x0lp44
Mean Corpuscular Hemoglobin (MCH)
Mean Corpuscular Hemoglobin (MCH)
Float
Blood measurements (CHRIS baseline)
x0lp45
Mean Corpuscular Hemoglobin Concentration (MCHC)
Mean Corpuscular Hemoglobin Concentration (MCHC)
Float
Blood measurements (CHRIS baseline)
x0lp43
Mean Corpuscular Volume (MCV)
Mean Corpuscular Volume (MCV)
Float
Heart rate variability, cardiologist curated (CHRIS baseline)
x0ec43
Mean Heart Rate
mean HR
Float
Blood measurements (CHRIS baseline)
x0lp48
Mean Platelet Volume (MPV)
Mean Platelet Volume (MPV)
Float
ECG 10s (CHRIS baseline)
x0ec124a
Mean of RR-Intervals
Mean of RR-Intervals (computed over the customed beat series), expressed in milliseconds
Float
ECG 10s (CHRIS baseline)
x0ec124b
Median of RR-Intervals
Median of RR-Intervals (computed over the customed beat series), expressed in milliseconds
Float
Gynecology (CHRIS baseline)
x0wo01b
Menarche
How old were you at your first menstruation (menarche)?
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt019
Met
Methionine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt020
Met-SO
Methioninesulfoxide
Float
Migraine (CHRIS baseline)
x0mg21
Migraine (since)
How many years have you been suffering from headaches?
Float
Heart rate variability, cardiologist curated (CHRIS baseline)
x0ec41
Minimum Heart Rate
minimum HR
Float
Blood measurements (CHRIS baseline)
x0lp50c
Monocytes (MONO)
Monocytes (MONO)
Float
Blood measurements (CHRIS baseline)
x0lp50h
Monocytes (absolute monocyte count)
Monocytes (absolute monocyte count)
Float
Neutralizing Antibody (CHRIS COVID-19)
ccna01
Neutralizing antibody ID50 value
Neutralizing antibody ID50 value
Float
Blood measurements (CHRIS baseline)
x0lp50a
Neutrophils (NEUT)
Neutrophils (NEUT)
Float
Blood measurements (CHRIS baseline)
x0lp50f
Neutrophils (absolute neutrophil count)
Neutrophils (absolute neutrophil count)
Float
ECG 10s (CHRIS baseline)
x0ec143a
Noise, I
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead I
Float
ECG 10s (CHRIS baseline)
x0ec143b
Noise, II
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec143c
Noise, III
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec143g
Noise, V1
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec143h
Noise, V2
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec143i
Noise, V3
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec143j
Noise, V4
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec143k
Noise, V5
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec143l
Noise, V6
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec143f
Noise, aVF
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec143e
Noise, aVL
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec143d
Noise, aVR
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead aVR
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt021
Orn
Ornithine
Float
Chronic pain (CHRIS baseline)
x0pn22
Other pain since (years)
Since when is this pain present? (years)
Float
ECG 10s (CHRIS baseline)
x0ec106a
P-Amplitude negative, I
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead I
Float
ECG 10s (CHRIS baseline)
x0ec106b
P-Amplitude negative, II
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec106c
P-Amplitude negative, III
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec106g
P-Amplitude negative, V1
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec106h
P-Amplitude negative, V2
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec106i
P-Amplitude negative, V3
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec106j
P-Amplitude negative, V4
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec106k
P-Amplitude negative, V5
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec106l
P-Amplitude negative, V6
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec106f
P-Amplitude negative, aVF
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec106e
P-Amplitude negative, aVL
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec106d
P-Amplitude negative, aVR
Peak amplitude of the negative deflection of P wave, expressed in milliVolts, measured in lead aVR
Float
ECG 10s (CHRIS baseline)
x0ec105a
P-Amplitude positive, I
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead I
Float
ECG 10s (CHRIS baseline)
x0ec105b
P-Amplitude positive, II
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec105c
P-Amplitude positive, III
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec105g
P-Amplitude positive, V1
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V1
Float
ECG 10s (CHRIS baseline)
x0ec105h
P-Amplitude positive, V2
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec105i
P-Amplitude positive, V3
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec105j
P-Amplitude positive, V4
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec105k
P-Amplitude positive, V5
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V5
Float
ECG 10s (CHRIS baseline)
x0ec105l
P-Amplitude positive, V6
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec105f
P-Amplitude positive, aVF
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead aVF
Float
ECG 10s (CHRIS baseline)
x0ec105e
P-Amplitude positive, aVL
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec105d
P-Amplitude positive, aVR
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead aVR
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt086
PC aa C24:0
Phosphatidylcholine diacyl C24:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt087
PC aa C26:0
Phosphatidylcholine diacyl C26:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt088
PC aa C28:1
Phosphatidylcholine diacyl C28:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt089
PC aa C30:0
Phosphatidylcholine diacyl C30:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt090
PC aa C30:2
Phosphatidylcholine diacyl C30:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt091
PC aa C32:0
Phosphatidylcholine diacyl C32:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt092
PC aa C32:1
Phosphatidylcholine diacyl C32:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt093
PC aa C32:2
Phosphatidylcholine diacyl C32:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt094
PC aa C32:3
Phosphatidylcholine diacyl C32:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt095
PC aa C34:1
Phosphatidylcholine diacyl C34:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt096
PC aa C34:2
Phosphatidylcholine diacyl C34:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt097
PC aa C34:3
Phosphatidylcholine diacyl C34:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt098
PC aa C34:4
Phosphatidylcholine diacyl C34:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt099
PC aa C36:0
Phosphatidylcholine diacyl C36:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt100
PC aa C36:1
Phosphatidylcholine diacyl C36:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt101
PC aa C36:2
Phosphatidylcholine diacyl C36:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt102
PC aa C36:3
Phosphatidylcholine diacyl C36:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt103
PC aa C36:4
Phosphatidylcholine diacyl C36:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt104
PC aa C36:5
Phosphatidylcholine diacyl C36:5
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt105
PC aa C36:6
Phosphatidylcholine diacyl C36:6
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt106
PC aa C38:0
Phosphatidylcholine diacyl C38:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt107
PC aa C38:1
Phosphatidylcholine diacyl C38:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt108
PC aa C38:3
Phosphatidylcholine diacyl C38:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt109
PC aa C38:4
Phosphatidylcholine diacyl C38:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt110
PC aa C38:5
Phosphatidylcholine diacyl C38:5
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt111
PC aa C38:6
Phosphatidylcholine diacyl C38:6
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt112
PC aa C40:1
Phosphatidylcholine diacyl C40:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt113
PC aa C40:2
Phosphatidylcholine diacyl C40:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt114
PC aa C40:3
Phosphatidylcholine diacyl C40:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt115
PC aa C40:4
Phosphatidylcholine diacyl C40:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt116
PC aa C40:5
Phosphatidylcholine diacyl C40:5
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt117
PC aa C40:6
Phosphatidylcholine diacyl C40:6
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt118
PC aa C42:0
Phosphatidylcholine diacyl C42:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt119
PC aa C42:1
Phosphatidylcholine diacyl C42:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt120
PC aa C42:2
Phosphatidylcholine diacyl C42:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt121
PC aa C42:4
Phosphatidylcholine diacyl C42:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt122
PC aa C42:5
Phosphatidylcholine diacyl C42:5
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt123
PC aa C42:6
Phosphatidylcholine diacyl C42:6
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt124
PC ae C30:0
Phosphatidylcholine acyl-alkyl C30:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt125
PC ae C30:1
Phosphatidylcholine acyl-alkyl C30:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt126
PC ae C30:2
Phosphatidylcholine acyl-alkyl C30:2
Float
Previous
1
8
9
10
11
12
43
Next